{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:21:41Z","timestamp":1787764901873,"version":"build-2784847793"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>The hepatitis C virus is an important cause of chronic hepatitis and primary hepatocellular carcinomas. Early treatment of HCV infection, especially in the acute phase, can facilitate elimination of the virus and prevent chronic infection. This will limit HCV-related liver damage and mortality. This study provides the current clinical-epidemiologic pattern, risk factors and seroprevalence of hepatitis C in clinical suspected cases attending different departments of a tertiary care centre.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>The study was conducted for a period of 1 year (March 2023 to March 2024) in the Department of Microbiology, AIIMS, Raebareli. After obtaining ethical clearance, serum samples were collected from all patients referred to the Department of Microbiology to determine antibodies against HCV. An ELISA was performed for anti-HCV antibodies and HBsAg. The results and relevant clinical information were noted and analysed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Of the 16911 samples, 127 (0.75%) were positive for anti-HCV antibodies. Of the 127 anti-HCV positive samples, 88 (69.3%) samples had an S\/Co ratio &gt;5.0, while 39 (30.7%) samples had an S\/Co ratio &lt;5.0. Majority of the cases were in the age group 46-60 years (31%), followed by the age group 31-45 years (26.%) and 61-75 years (26.%). The number of male cases (55.91%) was slightly higher than female cases (44.09%). In our study, serum bilirubin was elevated in 29.8% (29\/127) of anti-HCV seropositive patients, alanine transaminase (ALT) was elevated in 56.7% (72\/127) of seropositive patients and 49.6% (63\/127) of seropositive patients had elevated aspartate transaminase (AST). A history of surgery (30.9%) was the most important risk factor in the seropositive patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The study shows the seroprevalence of hepatitis C virus in patients with clinical suspicion, with 0.75% of samples testing positive for anti-HCV antibodies. Most positive cases were observed in adults aged 46-60 years, with elevated ALT and AST levels found in several seropositive patients. Surgical history has emerged as a notable risk factor.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/aam.aam_216_24","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T17:01:53Z","timestamp":1753290113000},"page":"791-795","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Clinico-epidemiological Patterns, Risk Factors, and Seroprevalence of Hepatitis C in Patients Attending a Tertiary Care Center in North India"],"prefix":"10.4103","volume":"24","author":[{"given":"Sana","family":"Islahi","sequence":"first","affiliation":[{"name":"Department of Microbiology, All India Institute of Medical Sciences, Raebareli, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sweta","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Microbiology, All India Institute of Medical Sciences, Raebareli, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shefali","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Microbiology, All India Institute of Medical Sciences, Raebareli, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Altaf Ahmad","family":"Mir","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, All India Institute of Medical Sciences Hospital, Raebareli, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arti","family":"Dwiwedi","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, All India Institute of Medical Sciences Hospital, Raebareli, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhalesh Kumar","family":"Shakya","sequence":"additional","affiliation":[{"name":"Department of Microbiology, All India Institute of Medical Sciences, Raebareli, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Dwiwedi","sequence":"additional","affiliation":[{"name":"Department of Microbiology, VRDL, All India Institute of Medical Sciences, Raebareli, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somdatt","family":"Sen","sequence":"additional","affiliation":[{"name":"Department of Microbiology, VRDL, All India Institute of Medical Sciences, Raebareli, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"key":"R4-20251015","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.jhep.2019.11.012","article-title":"Hepatitis C reinfection after successful antiviral treatment among people who inject drugs:A meta-analysis","volume":"72","author":"Hajarizadeh","year":"2020","journal-title":"J Hepatol"},{"key":"R5-20251015","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.26141","article-title":"Global epidemiology of hepatitis C virus infection:New estimates of age-specific antibody to HCV seroprevalence","volume":"57","author":"Mohd Hanafiah","year":"2013","journal-title":"Hepatology"},{"key":"R6-20251015","first-page":"183","article-title":"Characteristics of dual infection of hepatitis B and C viruses among patients with chronic liver disease:A study from tertiary care hospital","volume":"26","author":"Chakravarti","year":"2005","journal-title":"Trop Gastroenterol"},{"key":"R7-20251015","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/jmv.1890110303","article-title":"Interference between non-A, non-B and hepatitis B virus infection in chimpanzees","volume":"11","author":"Brotman","year":"1983","journal-title":"J Med Virol"},{"key":"R8-20251015","first-page":"101356","article-title":"A study of seroprevalence and the associated risk factors of hepatitis C at a tertiary care hospital in Mumbai Clinical Epidemiology and Global Health","volume":"23","author":"Ingle","year":"2023"},{"key":"R9-20251015","doi-asserted-by":"crossref","first-page":"21956","DOI":"10.1038\/s41598-024-71363-w","article-title":"Seroprevalence of hepatitis B and hepatitis C virus among clinically suspected cases of viral hepatitis visiting Guhalla primary hospital, Northwest Ethiopia","volume":"14","author":"Belete","year":"2024","journal-title":"Sci Rep"},{"key":"R10-20251015","first-page":"329","article-title":"Viral hepatitides in voluntary blood donors in Yola, Nigeria","volume":"31","author":"Olokoba","year":"2009","journal-title":"Eur J Sci Res"},{"key":"R12-20251015","doi-asserted-by":"crossref","first-page":"219","DOI":"10.4314\/ajcem.v17i3.10","article-title":"Seroprevalence of hepatitis C virus (Hcv) antibodies in pregnant women in Anyigba, Kogi State, North Central Nigeria","volume":"17","author":"Nwankwo","year":"2016","journal-title":"Afr J Clin Exp Microbiol"},{"key":"R13-20251015","first-page":"7","article-title":"Prevalence and risk factors of hepatitis B and hepatitis C virus infections among patients with chronic liver diseases in public hospitals in Addis Ababa, Ethiopia","volume":"2013","author":"Ayele","year":"2013","journal-title":"Int Sch Res Notices"},{"key":"R14-20251015","first-page":"953","article-title":"Seroprevalence of hepatitis B and C and pattern of liver function tests in hepatitis positive patients in Abbottabad","volume":"3","author":"Anjum","year":"2015","journal-title":"Sch J Appl Med Sci"},{"key":"R15-20251015","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2334-8-25","article-title":"Seroprevalence of hepatitis C and associated risk factors in urban areas of Antananarivo, Madagascar","volume":"8","author":"Ramarokoto","year":"2008","journal-title":"BMC Infect Dis"},{"key":"R16-20251015","doi-asserted-by":"crossref","first-page":"1280427","DOI":"10.3389\/fpubh.2023.1280427","article-title":"Patterns and trends of hepatitis C virus infection in Jordan:An observational study","volume":"11","author":"Abu-Dayyeh","year":"2023","journal-title":"Front Public Health"},{"key":"R17-20251015","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ijid.2023.08.004","article-title":"Molecular characterization of patients with chronic hepatitis C virus infection in Jordan:Implications on response to direct-acting antiviral therapy","volume":"135","author":"Fuentes","year":"2023","journal-title":"Int J Infect Dis"},{"key":"R18-20251015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cgh.2017.04.038","article-title":"Magnitude and kinetics of decrease in liver stiffness after antiviral therapy in patients with chronic hepatitis C:A systematic review and meta-analysis","volume":"16","author":"Singh","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R19-20251015","first-page":"502","article-title":"Relationship of liver enzymes with viral load of hepatitis C in HCV infected patients by data analytics (data analytics of HCV and liver profile)","volume":"9","author":"Ahmad","year":"2018","journal-title":"Int J Adv Comput Sci Appl"},{"key":"R20-20251015","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1007\/s42399-020-00588-3","article-title":"Update on hepatitis C epidemiology:Unaware and untreated infected population could be the key to elimination","volume":"2","author":"Stasi","year":"2020","journal-title":"SN Compr Clin Med"},{"key":"R21-20251015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40249-019-0528-6","article-title":"Epidemiology and management of hepatitis C virus infections in immigrant populations","volume":"8","author":"Coppola","year":"2019","journal-title":"Infect Dis Poverty"},{"key":"R22-20251015","doi-asserted-by":"crossref","first-page":"207","DOI":"10.5009\/gnl19005","article-title":"Epidemiological and clinical characteristics of hepatitis C virus infection in South Korea from 2007 to 2017:A prospective multicenter cohort study","volume":"14","author":"Nam","year":"2020","journal-title":"Gut Liver"},{"key":"R23-20251015","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/liv.13930","article-title":"Cost-effectiveness and health-related outcomes of screening for hepatitis C in Korean population","volume":"39","author":"Kim","year":"2019","journal-title":"Liver Int"},{"key":"R24-20251015","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1038\/s41598-017-17936-4","article-title":"Characterizing hepatitis C virus epidemiology in Egypt:Systematic reviews, meta-analyses, and meta-regressions","volume":"8","author":"Kouyoumjian","year":"2018","journal-title":"Sci Rep"}],"container-title":["Annals of African Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/aam.aam_216_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:51:27Z","timestamp":1787763087000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aam.aam_216_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/aam.aam_216_24","relation":{},"ISSN":["1596-3519","0975-5764"],"issn-type":[{"value":"1596-3519","type":"print"},{"value":"0975-5764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,23]]},"assertion":[{"value":"2024-10-20","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-12","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}